+157.2%
MRNA vs ENTG
+20.1%
+137.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | ENTG | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.2% | +3.2% | +5.6% |
| 7D | -1.1% | +1.2% | -2.3% | -1.0% |
| 30D | +126.1% | -12.9% | +139.0% | +128.8% |
| 3M | +190.0% | -3.1% | +193.1% | +168.3% |
| 6M | +157.2% | +21.0% | +136.2% | +108.6% |
| All | +157.2% | +20.1% | +137.2% | +108.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ENTG.
Daily Out/Under-Performance
Portfolio return minus ENTG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENTG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded ENTG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling